FRIDAY, Jan. 14, 2022 (HealthDay News) — Unvaccinated pregnant women are putting themselves and their baby at risk for serious complications of COVID-19, according to new research out of Scotland. For women who have the virus within 28 days of their delivery date, those complications include preterm births, stillbirths andContinue Reading
FRIDAY, Jan. 14, 2022 (HealthDay News) — The Biden administration can’t enforce a vaccine-or-testing mandate for large employers, the U.S. Supreme Court ruled Thursday. The 6-3 decision was driven by the conservative majority on the court. The mandate was a crucial component of the White House’s plan to tackle theContinue Reading
FRIDAY, Jan. 14, 2022 (HealthDay News) — As the Omicron variant rages across the United States, an expert outlines how to reduce your risk of getting infected with COVID-19. Be cautious when it comes to social activities and consider the amount of risk you’re willing to accept in order toContinue Reading
FRIDAY, Jan. 14, 2022 (HealthDay News) — One in 10 people with COVID-19 could still be infectious beyond 10 days, and some could remain so for as long as two months, a new study suggests. U.K. researchers reported that a new test can detect whether the coronavirus is potentially stillContinue Reading
THURSDAY, Jan. 13, 2022 (HealthDay News) — Arthritis can keep a cat from doing many of the things that kitties love to do. But now there’s hope: The first treatment to ease arthritis pain in cats has been approved by the U.S. Food and Drug Administration. Solensia (frunevetmab injection) isContinue Reading
THURSDAY, Jan. 13, 2022 (HealthDay News) — Here’s more evidence that marijuana may make driving more dangerous: As pot has been legalized in more countries and states, a greater number of people are driving intoxicated by the drug and crashing, researchers report. THC, the active ingredient in cannabis, has beenContinue Reading
THURSDAY, Jan. 13, 2022 (HealthDay News) — The opioid addict you know might not be the college kid who has always dabbled in alcohol and drugs. It could be your grandparent. Opioid misuse doesn’t discriminate by age — and rates are rising steadily among adults aged 55 and up, newContinue Reading
WEDNESDAY, Jan. 12, 2022 (HealthDay News) — In a sign that the highly contagious Omicron variant is sparing no one, a new report shows that new COVID-19 cases among U.S. children spiked to a high of more than 580,000 for the week ending Jan. 6, a 78% increase from theContinue Reading
WEDNESDAY, Jan. 12, 2022 (HealthDay News) — People on bone-protecting drugs often take breaks from them for a few years. Now a new study finds that a “holiday” from the medication risedronate (Actonel) may come with a slightly increased risk of hip fracture. Researchers found that compared with a drugContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverageContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — Pfizer Inc. said Tuesday that a COVID-19 vaccine that specifically targets the Omicron variant will be ready by March. The company has already started making the new version of the vaccine, Pfizer CEO Albert Bourla told CNBC‘s “Squawk Box,” CBS News reported. OmicronContinue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker BiogenContinue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — Researchers say they’ve uncovered a clue to why the Omicron variant spreads COVID-19 so much more rapidly than its predecessors. People who are infected but have no symptoms are still far more likely to infect others than they would have been with earlierContinue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — For people newly diagnosed with advanced melanoma, a combination of two immunotherapy drugs can double the amount of time their cancer remains progression-free, a clinical trial has found. The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), isContinue Reading